Clinical Trials Directory

Trials / Completed

CompletedNCT01851525

Therapeutic Outcomes Using Contact Force Handling During Atrial Fibrillation Ablation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Southlake Regional Health Centre · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

Catheter ablation has emerged as an effective therapy for atrial fibrillation (AF). However, achievement of complete\& durable isolation of the pulmonary veins (PVs) is challenging, primary limited both by operator experience and also the limits of currently available ablation technology. Direct contact force sensing (CFS) is a novel technology that may help to ensure adequate lesion delivery. CFS may also help to improve the safety profile of catheter ablation. The purpose of this study is to compare two strategies of wide antral PV isolation plus linear ablation for persistent AF: 1. guided by contact force sensing (CFS) OR 2. blinded to contact force sensing (CFS) - i.e. standard approach

Conditions

Interventions

TypeNameDescription
DEVICEThermoCoolSmartTouch ablation catheter, Biosense Webster

Timeline

Start date
2013-06-01
Primary completion
2017-02-15
Completion
2017-02-15
First posted
2013-05-10
Last updated
2017-04-25

Locations

4 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT01851525. Inclusion in this directory is not an endorsement.